Environmental triggers: Smoking, infections, and exposure to certain chemicals may initiate or worsen the disease.Primary Biliary Cholangitis SymptomsEarly symptoms of PBC may be mild or absent.

The EMA has started a review of GSK's treatment candidate for primary biliary cholangitis (PBC), linerixibat, offering hope ...

DelveInsight's NADPH Oxidase (NOX)-Replacement Therapies Market Size, Target Population, Competitive Landscape & Market ...

EMA accepts GSK’s MAA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Tuesday, June 24, 2025, 09:00 Hrs [IST] GSK plc announced ...

FDA approves Ipsen's Iqirvo for primary biliary cholangitis, ending a 10-year hiatus in new therapies for the rare cholestatic liver disease.

Primary billiary cholangitis, or PBC, is a chronic disease that gradually damages the bile ducts, and eventually your liver. You may also hear it called primary billiary cirrhosis.

GSK's marketing application for linerixibat, targeting cholestatic pruritus in PBC patients, gains EMA acceptance based on phase III success.

The FDA has accepted for review the NDA for linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.

For the millions of Americans battling autoimmune disorders, new hope may be on the horizon in the form of reverse or inverse ...

The NHS says that itchy skin is usually nothing to be worried about, and can be caused by everything from eczema to allergies ...

According to the latest study from BCC Research, the "Liver Disease Treatments: The Global Market" is projected to increase from $46.0 ...